PRGO up +2.15% percent right now. $PRGO High is at 155.89 and the Low 152.62 with current volume of 1,927,000.
Recent News posted below.
PRGO Perrigo Company Recent Headline News
Perrigo to re-launch the expectorant tablets Guaifenesin Extended-Release 600mg in the US
M2 - Fri Nov 07, 6:22AM CST
Healthcare company Perrigo Company (NYSE
RGO) said on Thursday that it has re-initiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the US.
PRGO: 155.77 (+3.28)
Perrigo to buy Omega Pharma
at Investor's Business Daily - Thu Nov 06, 5:49PM CST
The Ireland-based pharmaceuticals maker agreed to buy Belgium-based Omega Pharma for $4.5 bil, including debt, in a deal designed to expand Perrigo's (PRGO) presence in Europe. In its fiscal Q1, Perrigo earned $1.40 a share, missing views by 4 cents,...
PRGO: 155.77 (+3.28)
After Yesterday's Decline of 3.79%, Perrigo Offers Investors Better Value
Comtex SmarTrend(R) - Thu Nov 06, 3:41PM CST
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $145.41 to a high of $160.85. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $158.30 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PRGO: 155.77 (+3.28)
Perrigo (PRGO) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Nov 06, 3:39PM CST
The following Perrigo (PRGO) conference call took place on November 6, 2014, 10:00 AM ET. This is a transcript of that earnings call:
PRGO: 155.77 (+3.28)
Perrigo Misses on Earnings and Sales, Maintains Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:08AM CST
Perrigo Companys reported first-quarter fiscal 2015 earnings of $1.40 per share.
AGN: 196.00 (-1.40), BIIB: 320.75 (-2.72), PRGO: 155.77 (+3.28), ABBV: 61.50 (-1.21)
Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets
PR Newswire - Thu Nov 06, 5:39AM CST
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States. The product will be packaged and marketed under store and proprietary brands and will be a high quality, value alternative to Mucinex® 600mg Extended-Release tablets.
PRGO: 155.77 (+3.28)
Perrigo Company PLC Reports Record First Quarter Revenue, Adjusted Net Income And Adjusted Margins
PR Newswire - Thu Nov 06, 5:32AM CST
-- Fiscal first quarter net sales increased to a first quarter record of $952 million.
PRGO: 155.77 (+3.28)
Perrigo Company plc To Acquire Omega Pharma NV For EUR 3.6 Billion Creating A Top Five Global OTC Company
PR Newswire - Thu Nov 06, 5:26AM CST
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for EUR 3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for EUR 2.48 billion and the assumption of EUR 1.1 billion in debt. The transaction, funded through a combination of cash, debt, and equity, will enhance Perrigo's leading OTC product offering and expand its distribution through Omega's strong established platform.
PRGO: 155.77 (+3.28)
Will Perrigo (PRGO) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 3:45PM CST
Perrigo (PRGO), which is scheduled to report first-quarter fiscal 2015 results on Nov 6, had delivered a positive earnings surprise of 12.26%.
MDVN: 112.77 (+7.82), ACT: 245.91 (-4.47), PRGO: 155.77 (+3.28), ALNY: 95.84 (+2.93)
Financial Results, Appointments, and Upcoming Conference Calls - Research Reports on Yelp, Vantiv, Discovery, Vistaprint and Perrigo
PR Newswire - Tue Nov 04, 7:55AM CST
Today, Analysts Review released its research reports regarding Yelp, Inc. (NYSE: YELP), Vantiv, Inc. (NYSE: VNTV), Discovery Communications, Inc. (NASDAQ: DISCA), Vistaprint N.V. (NASDAQ: VPRT) and Perrigo Company Plc (NYSE: PRGO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7669-100free.
PRGO: 155.77 (+3.28), DISCA: 32.62 (-0.28), VPRT: 67.41 (+0.92), VNTV: 30.75 (+0.25), YELP: 58.41 (-0.37)
Perrigo Company plc Announces Quarterly Dividend
PR Newswire - Mon Nov 03, 2:12PM CST
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on November 28, 2014.
PRGO: 155.77 (+3.28)
Perrigo Rises 4.08% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Oct 30, 4:18PM CDT
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $153.00 to a high of $161.35. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $156.35 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 155.77 (+3.28)
Lannett Co. Gets Growth Rx In Generic Drugs Group
at Investor's Business Daily - Mon Oct 27, 4:59PM CDT
Generic-drug maker Lannett Co. boasts a robust pipeline and has its sights on growing revenue substantially over the next several years. The Philadelphia-based company is already on solid footing. In late August, it reported fiscal 2014...
LCI: 50.17 (-0.82), PRGO: 155.77 (+3.28), ACT: 245.91 (-4.47), AKRX: 36.59 (-1.29), TEVA: 57.70 (-1.02)
Technical Report on Pharma Stocks - Auxilium Pharma, Perrigo, Endo Intl., Depomed, and Ampio Pharma
PR Newswire - Fri Oct 24, 7:45AM CDT
Investor-Edge has initiated coverage on the following equities: Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Perrigo Company PLC (NYSE: PRGO), Endo International PLC (NASDAQ: ENDP), Depomed Inc. (NASDAQ: DEPO), and Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 23, 2014, the NASDAQ Composite ended at 4,452.79, up 1.60%, the Dow Jones Industrial Average advanced 1.32%, to finish the day at 16,677.90, and the S&P 500 closed at 1,950.82, up 1.23%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 744.13, up 1.75%, with the index also advancing 3.88% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
ENDP: 68.96 (-1.23), PRGO: 155.77 (+3.28), AUXL: 32.75 (-0.52), DEPO: 14.27 (-0.64), AMPE: 3.82 (+0.12)
Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014
PR Newswire - Thu Oct 23, 7:34AM CDT
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday, November 6, 2014 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer.
PRGO: 155.77 (+3.28)
SmarTrend Watching for Potential Pullback in Shares of Perrigo After 1.85% Gain
Comtex SmarTrend(R) - Mon Oct 20, 5:16PM CDT
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $146.39 to a high of $149.63. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $148.68 on volume of 964,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 155.77 (+3.28)
Perrigo CEO Constructs "Five Pillars" For Success
at Investor's Business Daily - Fri Oct 17, 4:03PM CDT
Trained as a pharmacist, Joseph Papa learned to scrutinize science when making a decision. Earning his bachelor's degree in pharmacy taught him to use Socratic questions to dig for answers. "The pharmaceuticals business comes down to what are you...
PRGO: 155.77 (+3.28), GILD: 106.45 (-0.49)
Perrigo Animal Health's Kansas manufacturing facility earns SQF Certification
M2 - Wed Oct 15, 6:57AM CDT
Perrigo Animal Health, a division of Perrigo Company (NYSE RGO)(NYSE:TASE) revealed on Tuesday that its Kansas manufacturing facility has successfully passed the Safety Quality Food (SQF) Code Edition 7.1, Level 2 Certification under the Global Food Safety Initiative (GFSI).
PRGO: 155.77 (+3.28)
ScinoPharm Recognized as API Supplier of the Year at Global Generics & Biosimilars Awards
PR Newswire - Wed Oct 15, 1:32AM CDT
ScinoPharm (TWSE:1789) announced that it was named the "Active Pharmaceutical Ingredient (API) Supplier of the Year" at the Global Generics and Biosimilars Awards co-hosted by Generics bulletin and Ark Patent Intelligence. The award recognizes excellent performance across a range of business activities and was won in strong competition against a number of leading Pharmaceutical companies including Dr. Reddy's, Teva, Perrigo, Unichem, etc.
PRGO: 155.77 (+3.28)
Perrigo Animal Health Receives SQF Certification
PR Newswire - Tue Oct 14, 9:25AM CDT
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), is proud to announce that its Kansas City, Kansas, manufacturing facility has obtained Safety Quality Food (SQF) Code Edition 7.1, Level 2 Certification. The SQF registration covers the production of all pet treats manufactured in the Kansas-based plant.
PRGO: 155.77 (+3.28)
Recent News posted below.
PRGO Perrigo Company Recent Headline News
Perrigo to re-launch the expectorant tablets Guaifenesin Extended-Release 600mg in the US
M2 - Fri Nov 07, 6:22AM CST
Healthcare company Perrigo Company (NYSE
RGO) said on Thursday that it has re-initiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the US. PRGO: 155.77 (+3.28)
Perrigo to buy Omega Pharma
at Investor's Business Daily - Thu Nov 06, 5:49PM CST
The Ireland-based pharmaceuticals maker agreed to buy Belgium-based Omega Pharma for $4.5 bil, including debt, in a deal designed to expand Perrigo's (PRGO) presence in Europe. In its fiscal Q1, Perrigo earned $1.40 a share, missing views by 4 cents,...
PRGO: 155.77 (+3.28)
After Yesterday's Decline of 3.79%, Perrigo Offers Investors Better Value
Comtex SmarTrend(R) - Thu Nov 06, 3:41PM CST
Perrigo (NASDAQ
RGO) traded in a range yesterday that spanned from a low of $145.41 to a high of $160.85. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $158.30 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. PRGO: 155.77 (+3.28)
Perrigo (PRGO) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Nov 06, 3:39PM CST
The following Perrigo (PRGO) conference call took place on November 6, 2014, 10:00 AM ET. This is a transcript of that earnings call:
PRGO: 155.77 (+3.28)
Perrigo Misses on Earnings and Sales, Maintains Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:08AM CST
Perrigo Companys reported first-quarter fiscal 2015 earnings of $1.40 per share.
AGN: 196.00 (-1.40), BIIB: 320.75 (-2.72), PRGO: 155.77 (+3.28), ABBV: 61.50 (-1.21)
Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets
PR Newswire - Thu Nov 06, 5:39AM CST
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States. The product will be packaged and marketed under store and proprietary brands and will be a high quality, value alternative to Mucinex® 600mg Extended-Release tablets.
PRGO: 155.77 (+3.28)
Perrigo Company PLC Reports Record First Quarter Revenue, Adjusted Net Income And Adjusted Margins
PR Newswire - Thu Nov 06, 5:32AM CST
-- Fiscal first quarter net sales increased to a first quarter record of $952 million.
PRGO: 155.77 (+3.28)
Perrigo Company plc To Acquire Omega Pharma NV For EUR 3.6 Billion Creating A Top Five Global OTC Company
PR Newswire - Thu Nov 06, 5:26AM CST
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for EUR 3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for EUR 2.48 billion and the assumption of EUR 1.1 billion in debt. The transaction, funded through a combination of cash, debt, and equity, will enhance Perrigo's leading OTC product offering and expand its distribution through Omega's strong established platform.
PRGO: 155.77 (+3.28)
Will Perrigo (PRGO) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 3:45PM CST
Perrigo (PRGO), which is scheduled to report first-quarter fiscal 2015 results on Nov 6, had delivered a positive earnings surprise of 12.26%.
MDVN: 112.77 (+7.82), ACT: 245.91 (-4.47), PRGO: 155.77 (+3.28), ALNY: 95.84 (+2.93)
Financial Results, Appointments, and Upcoming Conference Calls - Research Reports on Yelp, Vantiv, Discovery, Vistaprint and Perrigo
PR Newswire - Tue Nov 04, 7:55AM CST
Today, Analysts Review released its research reports regarding Yelp, Inc. (NYSE: YELP), Vantiv, Inc. (NYSE: VNTV), Discovery Communications, Inc. (NASDAQ: DISCA), Vistaprint N.V. (NASDAQ: VPRT) and Perrigo Company Plc (NYSE: PRGO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7669-100free.
PRGO: 155.77 (+3.28), DISCA: 32.62 (-0.28), VPRT: 67.41 (+0.92), VNTV: 30.75 (+0.25), YELP: 58.41 (-0.37)
Perrigo Company plc Announces Quarterly Dividend
PR Newswire - Mon Nov 03, 2:12PM CST
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on November 28, 2014.
PRGO: 155.77 (+3.28)
Perrigo Rises 4.08% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Oct 30, 4:18PM CDT
Perrigo (NASDAQ
RGO) traded in a range yesterday that spanned from a low of $153.00 to a high of $161.35. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $156.35 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PRGO: 155.77 (+3.28)
Lannett Co. Gets Growth Rx In Generic Drugs Group
at Investor's Business Daily - Mon Oct 27, 4:59PM CDT
Generic-drug maker Lannett Co. boasts a robust pipeline and has its sights on growing revenue substantially over the next several years. The Philadelphia-based company is already on solid footing. In late August, it reported fiscal 2014...
LCI: 50.17 (-0.82), PRGO: 155.77 (+3.28), ACT: 245.91 (-4.47), AKRX: 36.59 (-1.29), TEVA: 57.70 (-1.02)
Technical Report on Pharma Stocks - Auxilium Pharma, Perrigo, Endo Intl., Depomed, and Ampio Pharma
PR Newswire - Fri Oct 24, 7:45AM CDT
Investor-Edge has initiated coverage on the following equities: Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Perrigo Company PLC (NYSE: PRGO), Endo International PLC (NASDAQ: ENDP), Depomed Inc. (NASDAQ: DEPO), and Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 23, 2014, the NASDAQ Composite ended at 4,452.79, up 1.60%, the Dow Jones Industrial Average advanced 1.32%, to finish the day at 16,677.90, and the S&P 500 closed at 1,950.82, up 1.23%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 744.13, up 1.75%, with the index also advancing 3.88% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
ENDP: 68.96 (-1.23), PRGO: 155.77 (+3.28), AUXL: 32.75 (-0.52), DEPO: 14.27 (-0.64), AMPE: 3.82 (+0.12)
Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014
PR Newswire - Thu Oct 23, 7:34AM CDT
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday, November 6, 2014 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer.
PRGO: 155.77 (+3.28)
SmarTrend Watching for Potential Pullback in Shares of Perrigo After 1.85% Gain
Comtex SmarTrend(R) - Mon Oct 20, 5:16PM CDT
Perrigo (NASDAQ
RGO) traded in a range yesterday that spanned from a low of $146.39 to a high of $149.63. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $148.68 on volume of 964,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. PRGO: 155.77 (+3.28)
Perrigo CEO Constructs "Five Pillars" For Success
at Investor's Business Daily - Fri Oct 17, 4:03PM CDT
Trained as a pharmacist, Joseph Papa learned to scrutinize science when making a decision. Earning his bachelor's degree in pharmacy taught him to use Socratic questions to dig for answers. "The pharmaceuticals business comes down to what are you...
PRGO: 155.77 (+3.28), GILD: 106.45 (-0.49)
Perrigo Animal Health's Kansas manufacturing facility earns SQF Certification
M2 - Wed Oct 15, 6:57AM CDT
Perrigo Animal Health, a division of Perrigo Company (NYSE
RGO)(NYSE:TASE) revealed on Tuesday that its Kansas manufacturing facility has successfully passed the Safety Quality Food (SQF) Code Edition 7.1, Level 2 Certification under the Global Food Safety Initiative (GFSI). PRGO: 155.77 (+3.28)
ScinoPharm Recognized as API Supplier of the Year at Global Generics & Biosimilars Awards
PR Newswire - Wed Oct 15, 1:32AM CDT
ScinoPharm (TWSE:1789) announced that it was named the "Active Pharmaceutical Ingredient (API) Supplier of the Year" at the Global Generics and Biosimilars Awards co-hosted by Generics bulletin and Ark Patent Intelligence. The award recognizes excellent performance across a range of business activities and was won in strong competition against a number of leading Pharmaceutical companies including Dr. Reddy's, Teva, Perrigo, Unichem, etc.
PRGO: 155.77 (+3.28)
Perrigo Animal Health Receives SQF Certification
PR Newswire - Tue Oct 14, 9:25AM CDT
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), is proud to announce that its Kansas City, Kansas, manufacturing facility has obtained Safety Quality Food (SQF) Code Edition 7.1, Level 2 Certification. The SQF registration covers the production of all pet treats manufactured in the Kansas-based plant.
PRGO: 155.77 (+3.28)
